Follow
CombiGene AB
Nasdaq First North GM (Sweden)
CombiGene AB is a gene therapy explorer based in Sweden. The company is engaged in developing new methods for the treatment of neurological diseases and for epileptic patients who cannot be helped by available medical treatments at present.
Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Exercise
Price
0.50 SEK
Exercise period(s)
16 Nov - 30 Nov 2020
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
COMBI
SE0006504593
Nasdaq First North GM
Sweden (SE)
Details of share in CombiGene AB with ticker COMBI
Status
Active
Order book id
4133
Amount of instruments
178 222 176
Par value
0.1000
Market cap
Currency
SEK
Segment
First North
First trading date
25 May 2015
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
5.00 SEK
44.22M SEK
08 Apr - 22 Apr 2015
IPO in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Exercise
7.50 SEK
12 Oct - 21 Oct 2015
08 Feb - 17 Feb 2016
Option exercise terms for COMBI TO 1
Type
Price
Pre-money valuation
Time
Files
Rights issue
3.00 SEK
35.4M SEK
06 Feb - 20 Feb 2017
Share issue in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
3.40 SEK
56.18M SEK
12 Feb - 28 Feb 2018
Share issue in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.90 SEK
15.48M SEK
04 Sep - 18 Sep 2018
Share issue in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Market move
19 Dec 2018
Listing of CombiGene AB on Nasdaq First North GM
Type
Price
Pre-money valuation
Time
Files
Exercise
2.00 SEK
01 Sep - 30 Sep 2019
Option exercise terms for COMBI TO 2
Type
Price
Pre-money valuation
Time
Files
Set-off issue
1.1339 SEK
24 Oct 2019
Share issue in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.50 SEK
32.53M SEK
20 Mar - 03 Apr 2020
Share issue in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Private placement
0.50 SEK
58.81M SEK
24 Apr 2020
Share issue in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Directed issue
0.72 SEK
90.45M SEK
04 Aug 2020
Share issue in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Exercise
0.60 SEK
17 Aug - 31 Aug 2020
Option exercise terms for COMBI TO 3
Type
Price
Pre-money valuation
Time
Files
Directed issue
0.9606 SEK
169.59M SEK
16 Sep 2020
Share issue in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Exercise
0.50 SEK
16 Nov - 30 Nov 2020
Option exercise terms for COMBI TO 4
Type
Ticker
ISIN
Market
SHARE
COMBI
SE0006504593
Nasdaq First North GM
Sweden (SE)
Details of share in CombiGene AB with ticker COMBI
Status
Active
Order book id
4133
Amount of instruments
178 222 176
Par value
0.1000
Market cap
Currency
SEK
Segment
First North
First trading date
25 May 2015
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
5.00 SEK
44.22M SEK
08 Apr - 22 Apr 2015
IPO in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
3.00 SEK
35.4M SEK
06 Feb - 20 Feb 2017
Share issue in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
3.40 SEK
56.18M SEK
12 Feb - 28 Feb 2018
Share issue in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.90 SEK
15.48M SEK
04 Sep - 18 Sep 2018
Share issue in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Market move
19 Dec 2018
Listing of CombiGene AB on Nasdaq First North GM
Type
Price
Pre-money valuation
Time
Files
Set-off issue
1.1339 SEK
24 Oct 2019
Share issue in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.50 SEK
32.53M SEK
20 Mar - 03 Apr 2020
Share issue in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Private placement
0.50 SEK
58.81M SEK
24 Apr 2020
Share issue in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Directed issue
0.72 SEK
90.45M SEK
04 Aug 2020
Share issue in CombiGene AB
Type
Price
Pre-money valuation
Time
Files
Directed issue
0.9606 SEK
169.59M SEK
16 Sep 2020
Share issue in CombiGene AB
Type
Ticker
ISIN
Market
OPTION
COMBI TO 1
SE0006510178
Nasdaq First North GM
Sweden (SE)
Details of option in CombiGene AB with ticker COMBI TO 1
Status
Archived
Order book id
109549
Amount of instruments
1 250 000
Market cap
Currency
SEK
Trading period
25 May 2015 - 15 Feb 2016
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 7.50.
Update (12.10.2015): Today marks the start of the first subscription period for TO 1.
Update (08.02.2016): Today marks the start of the last subscription period for TO 1.
Type
Price
Pre-money valuation
Time
Files
Exercise
7.50 SEK
12 Oct - 21 Oct 2015
08 Feb - 17 Feb 2016
Option exercise terms for COMBI TO 1
Type
Ticker
ISIN
Market
OPTION
COMBI TO 2
SE0011616408
Nasdaq First North GM
Sweden (SE)
Details of option in CombiGene AB with ticker COMBI TO 2
Status
Archived
Order book id
165140
Amount of instruments
6 879 130
Market cap
Currency
SEK
Segment
First North
Trading period
19 Dec 2018 - 27 Sep 2019
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for price correspondning to seventy (70) percent volume-weighted average trading price at Nasdaq First North Sweden marketplace from the period of August 15, 2019 until August 28, 2019 but at least SEK 2.0 per share up to the maximum of SEK 2.50 per share. The subscription period with the support of warrants will take place from September 1, 2019 until September 30, 2019.
Update (24.10.2018): Information about CombiGene's warrant.
Type
Price
Pre-money valuation
Time
Files
Exercise
2.00 SEK
01 Sep - 30 Sep 2019
Option exercise terms for COMBI TO 2
Type
Ticker
ISIN
Market
OPTION
COMBI TO 3
SE0014111308
Nasdaq First North GM
Sweden (SE)
Details of option in CombiGene AB with ticker COMBI TO 3
Status
Archived
Order book id
196989
Amount of instruments
32 526 823
Market cap
Currency
SEK
Segment
First North
Trading period
20 May 2020 - 27 Aug 2020
Terms
One (1) warrant of series TO 3 entitles the holder to subscribe for one (1) new share in the Company for the subscription price which will be determined with the guidance of ten (10) trading days volume-weighted average price (VWAP) before the redemption with a discount of thirty (30) percent, but at least SEK 0.4 per share and a maximum of SEK 0.6 per share.
Update (17.08.2020): Exercise period for warrants of series TO3 in CombiGene begins today.
Type
Price
Pre-money valuation
Time
Files
Exercise
0.60 SEK
17 Aug - 31 Aug 2020
Option exercise terms for COMBI TO 3
Type
Ticker
ISIN
Market
OPTION
COMBI TO 4
SE0014111316
Nasdaq First North GM
Sweden (SE)
Details of option in CombiGene AB with ticker COMBI TO 4
Status
Archived
Order book id
196993
Amount of instruments
32 526 823
Market cap
Currency
SEK
Segment
First North
Trading period
20 May 2020 - 26 Nov 2020
Terms
One (1) warrant of series TO 4 entitles the holder to subscribe for one (1) new share in the Company for the subscription price which will be determined with the guidance of ten (10) trading days volume-weighted average price (VWAP) before the redemption with a discount of thirty (30) percent, but at least SEK 0.5 per share and a maximum of SEK 0.7 per share.
Update (16.11.2020): Exercise period for warrants of series TO4 and TO5 in CombiGene AB begins today.
Type
Price
Pre-money valuation
Time
Files
Exercise
0.50 SEK
16 Nov - 30 Nov 2020
Option exercise terms for COMBI TO 4
People
Number of Employees
3 people
Jan Nilsson
CEO
Bert Junno
Chairman of the board
Per Lundin
Board member
Jonas Ekblom
Board member
Peter Nilsson
Board member
Jan Nilsson
Board member
Company Details
Sector
HEALTH CARE

Address
Scheelevägen 2
Zip code
223 81
City/district
Lund
Country
Sweden (SE)
Registration number
556403-3818
LEI code
213800CITFPHX4TL8G93
First trade date
25 May 2015
Registration date
03 Oct 1990
Short name
CombiGene

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date